ARTICLE | Company News
Goodwin Biotechnology Inc., Neogenix Oncology deal
July 2, 2007 7:00 AM UTC
Goodwin will provide process development and manufacturing services for Neogenix's NPC-1C. The MAb is expected to enter Phase I and II trials to treat advanced pancreatic cancer in 1H08. Financial te...